News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
97,101 Results
Type
Article (2967)
Company Profile (12)
Press Release (94122)
Multimedia
Podcasts (3)
Webinars (2)
Section
Business (36414)
Career Advice (65)
Deals (6121)
Drug Delivery (13)
Drug Development (11884)
Employer Resources (13)
FDA (1949)
Job Trends (2361)
News (54038)
Policy (3034)
Tag
Academia (230)
Accelerated approval (3)
Allergies (30)
Alliances (3641)
ALS (33)
Alzheimer's disease (238)
Antibody-drug conjugate (ADC) (48)
Approvals (2035)
Artificial intelligence (130)
Autoimmune disease (15)
Automation (11)
Bankruptcy (55)
Best Places to Work (2394)
BIOSECURE Act (3)
Biosimilars (37)
Biotechnology (11)
Bladder cancer (61)
Brain cancer (9)
Breast cancer (173)
Cancer (1241)
Cardiovascular disease (95)
Career advice (62)
Career pathing (3)
CAR-T (56)
CDC (3)
Cell therapy (148)
Cervical cancer (15)
Clinical research (11627)
Collaboration (428)
Company closure (1)
Compensation (508)
Complete response letters (2)
COVID-19 (304)
CRISPR (22)
C-suite (128)
Cystic fibrosis (32)
Data (1341)
Depression (16)
Diabetes (98)
Diagnostics (1013)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (46)
Drug pricing (11)
Drug shortages (3)
Duchenne muscular dystrophy (45)
Earnings (31974)
Editorial (2)
Employer branding (1)
Employer resources (10)
Events (12390)
Executive appointments (353)
FDA (2806)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (4)
Funding (382)
Gene editing (42)
Generative AI (3)
Gene therapy (114)
GLP-1 (182)
Government (386)
Grass and pollen (2)
Guidances (274)
Healthcare (2916)
HIV (22)
Huntington's disease (6)
IgA nephropathy (24)
Immunology and inflammation (29)
Immuno-oncology (3)
Indications (17)
Infectious disease (368)
Inflammatory bowel disease (32)
Influenza (23)
Intellectual property (38)
Interviews (7)
IPO (4712)
IRA (3)
Job creations (252)
Job search strategy (53)
Kidney cancer (6)
Labor market (8)
Layoffs (38)
Leadership (1)
Legal (525)
Liver cancer (22)
Longevity (2)
Lung cancer (205)
Lymphoma (93)
Machine learning (8)
Management (5)
Manufacturing (128)
MASH (33)
Medical device (2324)
Medtech (2328)
Mergers & acquisitions (1721)
Metabolic disorders (249)
Multiple sclerosis (32)
NASH (5)
Neurodegenerative disease (35)
Neuropsychiatric disorders (8)
Neuroscience (449)
NextGen: Class of 2025 (743)
Non-profit (547)
Obesity (126)
Opinion (8)
Ovarian cancer (37)
Pain (29)
Pancreatic cancer (42)
Parkinson's disease (50)
Patents (70)
Patient recruitment (85)
Peanut (17)
People (3876)
Pharmaceutical (6)
Pharmacy benefit managers (2)
Phase I (3043)
Phase II (4804)
Phase III (4586)
Pipeline (1320)
Policy (14)
Postmarket research (438)
Preclinical (899)
Press Release (2)
Prostate cancer (68)
Psychedelics (7)
Radiopharmaceuticals (36)
Rare diseases (114)
Real estate (353)
Recruiting (2)
Regulatory (2764)
Reports (16)
Research institute (211)
Resumes & cover letters (4)
Rett syndrome (7)
RSV (26)
Schizophrenia (31)
Series A (54)
Series B (47)
Sickle cell disease (16)
Special edition (2)
Spinal muscular atrophy (13)
Sponsored (3)
Startups (211)
Stomach cancer (1)
Supply chain (30)
Tariffs (3)
The Weekly (3)
Vaccines (141)
Venture capital (10)
Weight loss (62)
Women's health (16)
Worklife (1)
Date
Today (26)
Last 7 days (138)
Last 30 days (721)
Last 365 days (12662)
2025 (8721)
2024 (8882)
2023 (7228)
2022 (8670)
2021 (8987)
2020 (8239)
2019 (6997)
2018 (5162)
2017 (4302)
2016 (3447)
2015 (4296)
2014 (2820)
2013 (1766)
2012 (2103)
2011 (2551)
2010 (2402)
Location
Africa (65)
Alabama (12)
Arizona (27)
Arkansas (4)
Asia (5193)
Australia (761)
California (3577)
Canada (788)
China (214)
Colorado (144)
Connecticut (172)
Delaware (141)
Europe (13741)
Florida (329)
Georgia (89)
Hawaii (2)
Idaho (7)
Illinois (260)
India (8)
Indiana (100)
Iowa (7)
Japan (137)
Kansas (13)
Kentucky (11)
Louisiana (8)
Maine (12)
Maryland (318)
Massachusetts (2666)
Michigan (95)
Minnesota (175)
Mississippi (1)
Missouri (37)
Montana (4)
Nebraska (2)
Nevada (41)
New Hampshire (23)
New Jersey (895)
New Mexico (6)
New York (781)
North Carolina (336)
North Dakota (2)
Northern California (1600)
Ohio (84)
Oklahoma (5)
Oregon (6)
Pennsylvania (474)
Puerto Rico (1)
Rhode Island (11)
South America (109)
South Carolina (3)
Southern California (1365)
Tennessee (56)
Texas (498)
United States (11553)
Utah (69)
Virginia (87)
Washington D.C. (18)
Washington State (250)
West Virginia (3)
Wisconsin (59)
97,101 Results for "36".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND
September 17, 2025
·
4 min read
Press Releases
Harmony Biosciences to Present Rare Epilepsy Data at the 36th International Epilepsy Congress
August 27, 2025
·
3 min read
Press Releases
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress
September 3, 2025
·
3 min read
Press Releases
Adial Pharmaceuticals Announces Pricing of $3.6 Million Public Offering
June 18, 2025
·
6 min read
Press Releases
Stoke Therapeutics and Biogen Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome
September 2, 2025
·
18 min read
Press Releases
Biogen and Stoke Therapeutics Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome
September 3, 2025
·
18 min read
Press Releases
Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline
August 26, 2025
·
8 min read
Press Releases
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress
August 25, 2025
·
15 min read
Press Releases
Biogen and Stoke Therapeutics Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress
August 25, 2025
·
15 min read
Press Releases
OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025
June 23, 2025
·
11 min read
1 of 9,711
Next
